Low SMA is reportedly a poor prognostic factor in patients with early-stage NSCLC who underwent surgery [5] as well as in those with advanced NSCLC who received chemotherapy or anti-PD-1 inhibitors [6, 7]. The gene discussed is SMN1; the disease is non-small cell lung carcinoma.